Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityZGNX / Zogenix, Inc. (98978L105)
President and CEOFARR STEPHEN J
IndustryPharmaceutical Preparations
Institutional Owners162
Institutional Shares37,715,204 - 107.07%
Institutional Value$ 43,847,744,000 USD

Institutional Stock Ownership and Shareholders()

ZGNX / Zogenix, Inc. Institutional Ownership

Zogenix, Inc. (NASDAQ:ZGNX) has 162 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,715,204 shares. Largest shareholders include Perceptive Advisors Llc, Scopia Capital Management Lp, BlackRock Inc., Cadian Capital Management, Lp, Vanguard Group Inc, Farallon Capital Management Llc, FMR LLC / Fidelity, Federated Investors Inc /pa/, venBio Select Advisor LLC, and BlackRock Fund Advisors.
Zogenix, Inc. (NASDAQ:ZGNX) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/zgnx"><img src="https://images.fintel.io/us-zgnx-so.png" alt="ZGNX / Zogenix, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR Cubist Systematic Strategies, LLC 0 1,616 0 65
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 0 13,837 0 554
2018-05-11 13F-HR Cutler Group LP Call 7,300 2,000 -72.60 85 12 -85.88
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 69,179 60,891 -11.98 2,771 2,439 -11.98
2018-05-17 13F-HR/A EVENTIDE ASSET MANAGEMENT, LLC 168,000 265,000 57.74 6,728 10,613 57.74
2018-05-11 13F-HR Mutual of America Capital Management LLC 30,529 49,429 61.91 1,223 1,980 61.90
2018-04-10 13F-HR NISA INVESTMENT ADVISORS L.L.C. 200 8
2018-04-23 13F-HR Advisory Services Network, LLC 125 125 0.00 5 5 0.00
2018-05-11 13F-HR HAP Trading, LLC Put 301,500 158
2018-05-08 13F-HR GW&K Investment Management, LLC 125,908 5,043
2018-05-15 13F-HR venBio Select Advisor LLC 1,263,313 1,189,213 -5.87 50,596 47,628 -5.87
2018-05-08 13F-HR Neuburgh Advisers LLC 6,600 264
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 1,460,233 1,461,263 0.07 58,482 58,524 0.07
2018-05-14 13F-HR Carillon Tower Advisers, Inc. 693,531 693,531 0.00 27,776 26,111 -5.99
2018-06-04 13F-HR Eam Global Investors Llc 29,350 29,350 0.00 1,175 1,175 0.00
2018-05-08 13F-HR TIVERTON ASSET MANAGEMENT LLC 20,000 801
2018-05-15 13F-HR Polar Capital LLP 447,954 17,939
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 542,283 563,602 3.93 6,198 6,848 10.49
2018-05-14 13F-HR BOGLE INVESTMENT MANAGEMENT L P /DE/ 34,133 0 -100.00 1,367 0 -100.00
2018-05-14 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 12,430 12,292 -1.11 497,822 492,295 -1.11
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 1,200 0 -100.00 48 0 -100.00
2018-05-02 13F-HR RHUMBLINE ADVISERS 32,438 34,097 5.11 1,299 1,366 5.16
2018-05-09 13F-HR BlackRock Inc. 2,656,444 2,614,893 -1.56 106,389 104,726 -1.56
2018-05-15 13F-HR BARCLAYS PLC 72,661 99,016 36.27 2,910 3,964 36.22
2018-05-14 13F-HR Virtu Financial LLC 17,043 0 -100.00 683 0 -100.00
2018-05-14 13F-HR Crawford Lake Capital Management, LLC 259,851 278,510 7.18 10,407 11,154 7.18
2018-04-25 13F-HR TOTH FINANCIAL ADVISORY CORP 500 0 -100.00 20 0 -100.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 77,624 62,122 -19.97 3,110 2,487 -20.03
2018-05-15 13F-HR Palo Alto Investors, LLC 29,500 29,500 0.00 1,181 1,181 0.00
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 44,400 66,100 48.87 1,778 2,647 48.88
2018-05-07 13F-HR BAILARD, INC. Put 18,900 103,000 444.97 1 569 56,800.00
2018-05-11 13F-HR CITIGROUP INC Call 31,600 11,300 -64.24 1,266 453 -64.22
2018-05-09 13F-HR EAGLE ASSET MANAGEMENT INC 994,399 992,170 -0.22 39,750 39,736 -0.04
2018-05-14 13F-HR TEACHERS ADVISORS INC 62,199 62,392 0.31 2,491 2,499 0.32
2018-05-15 13F-HR HIGHLAND CAPITAL MANAGEMENT LP 80,000 45,000 -43.75 3,204 1,802 -43.76
2017-02-10 13F-HR BlackRock Advisors LLC 12,845 13,390 4.24 147 163 10.88
2018-05-14 13F-HR INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 40 2
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 338,600 353,800 4.49 13,561 14,170 4.49
2018-05-15 13F-HR JANE STREET GROUP, LLC 7,465 0 -100.00 299 0 -100.00
2018-05-23 13F-HR/A Allianz Asset Management AG 42,940 42,940 0.00 1,720 1,720 0.00
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 115,100 30,100 -73.85 4,610 1,206 -73.84
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 0 2,323 0 93
2018-05-14 13F-HR Broadfin Capital, LLC 457,080 537,380 17.57 18,306 21,522 17.57
2018-05-11 13F-HR Quantbot Technologies LP 1,913 0 -100.00 76 0 -100.00
2018-05-14 13F-HR GREAT POINT PARTNERS LLC 1,121,331 978,302 -12.76 44,909 39,181,000 87,145.32
2018-05-11 13F-HR CITADEL ADVISORS LLC Call 44,000 1,762
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 69,500 44,000 -36.69 2,783 1,762 -36.69
2018-05-15 13F-HR J. Goldman & Co LP 71,129 37,638 -47.08 2,849 1,507 -47.10
2018-05-15 13F-HR Krilogy Financial LLC 200 200 0.00 8 8 0.00
2018-05-10 13F-HR Cheyne Capital Management (UK) LLP 44,500 1,781
2018-05-11 13F-HR Cutler Group LP Put 7,000 19,500 178.57 24 95 295.83
2018-04-20 13F-HR Cable Hill Partners, LLC 155 72 -53.55 5 3 -40.00
2018-05-15 13F-HR Point72 Asset Management, L.P. 0 104,329 0 4,178
2018-05-11 13F-HR CITIGROUP INC Put 1,000 7,300 630.00 40 292 630.00
2017-02-10 13F-HR BlackRock Fund Advisors 1,025,692 1,163,742 13.46 11,724 14,139 20.60
2018-05-15 13F-HR Schonfeld Strategic Advisors LLC 175,450 164,685 -6.14 7,027 6,596 -6.13
2018-05-09 13F-HR IFP Advisors, Inc 232 232 0.00 9 9 0.00
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 67,497 69,397 2.81 2,704 2,780 2.81
2018-05-14 13F-HR CADIAN CAPITAL MANAGEMENT, LP 1,545,605 2,154,274 39.38 61,901 86,279 39.38
2018-04-11 13F-HR Rhenman & Partners Asset Management AB 51,808 50,000 -3.49 2,075 2,003 -3.47
2018-05-10 13F-HR JP Morgan Chase & Co 130,020 93,692 -27.94 5,208 3,752 -27.96
2018-05-15 13F-HR ADVISORY RESEARCH INC 25,317 0 -100.00 1,014 0 -100.00
2018-05-08 13F-HR US BANCORP \DE\ 0 24 0 1
2018-05-21 13F-HR Winton Capital Group Ltd 9,387 376
2017-02-10 13F-HR Pyrrho Capital Management, LP 26,654 0 -100.00 305 0 -100.00
2018-05-15 13F-HR VOLORIDGE INVESTMENT MANAGEMENT, LLC 10,360 415
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 0 73,890 0 2,959
2018-05-15 13F-HR Endurant Capital Management LP 20,000 16,300 -18.50 801 653 -18.48
2018-05-15 13F-HR Aureus Asset Management, LLC 16,250 16,250 0.00 651 651 0.00
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 89,000 44,800 -49.66 3,564 1,794 -49.66
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 29,300 16,600 -43.34 1,173 665 -43.31
2018-05-15 13F-HR DEUTSCHE BANK AG\ 1,036,964 231,717 -77.65 41,529 9,279 -77.66
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 12,843 5,620 -56.24 514 226 -56.03
2018-05-08 13F-HR Tyers Asset Management LLC 8,400 337
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 921,554 36,908
2018-05-15 13F-HR Granite Point Capital Management, L.P. 146,500 131,100 -10.51 5,867 5,251 -10.50
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 32,000 0 -100.00 464 0 -100.00
2018-05-11 13F-HR LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 0 13,413 0 537
2018-05-15 13F-HR Invesco Ltd. 440,436 522,523 18.64 17,639 20,927 18.64
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 23,057 21,881 -5.10 923 876 -5.09
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 25,950 25,328 -2.40 1,039 1,014 -2.41
2018-05-15 13F-HR Advisor Group, Inc. 100 222 122.00 4 9 125.00
2018-05-15 13F-HR PEAK6 Investments, L.P. Put 0 20,000 0 801
2018-05-15 13F-HR Ghost Tree Capital, LLC 180,000 0 -100.00 7,209 0 -100.00
2018-05-15 13F-HR/A Sabby Management, LLC Put 1,114 687 -38.33 4,462 2,751 -38.35
2018-05-11 13F-HR STIFEL FINANCIAL CORP 5,890 10,189 72.99 234 410 75.21
2018-05-10 13F-HR FRED ALGER MANAGEMENT INC 15,000 20,000 33.33 601 801 33.28
2018-05-10 13F-HR Mirae Asset Global Investments Co., Ltd. 50,156 2,009
2018-05-14 13F-HR PURA VIDA INVESTMENTS, LLC 130,268 50,268 -61.41 5,217,233 2,013,233 -61.41
2018-05-15 13F-HR VANGUARD GROUP INC 1,499,667 1,583,771 5.61 60,061 63,429 5.61
2018-05-03 13F-HR DekaBank Deutsche Girozentrale 0 14,700 0 575
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 1,094 1,345 22.94 44 59 34.09
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 53,955 52,128 -3.39 2,161 2,088 -3.38
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 307,105 312,439 1.74 12,299 12,513 1.74
2018-04-18 13F-HR Creative Planning 25,165 16,865 -32.98 1,008 675 -33.04
2018-05-14 13F-HR MORGAN STANLEY 78,001 107,432 37.73 3,124 4,302 37.71
2018-05-15 13F-HR Quantitative Investment Management, LLC 15,300 0 -100.00 612 0 -100.00
2018-05-09 13F-HR NORTHERN TRUST CORP 442,876 443,736 0.19 17,737 17,771 0.19
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 633 389 -38.55 26 16 -38.46
2018-05-11 13F-HR TD ASSET MANAGEMENT INC 40,300 1,614
2018-05-15 13F-HR UBS Group AG 2,365 300 -87.32 95 12 -87.37
2018-04-25 13F-HR PICTET ASSET MANAGEMENT LTD 312,454 12,514
2018-05-15 13F-HR Bank of New York Mellon Corp 170,627 178,217 4.45 6,834 7,137 4.43
2018-05-11 13F-HR HSBC HOLDINGS PLC 74,608 0 -100.00 2,988 0 -100.00
2018-07-11 13F-HR Xact Kapitalforvaltning AB 7,300 323
2017-02-14 SC 13G/A RA Capital Healthcare Fund LP 0
2018-05-04 13F-HR PRUDENTIAL FINANCIAL INC 34,852 1,396
2018-05-15 13F-HR/A Sabby Management, LLC Call 3,090 4,059 31.36 12,375 16,256 31.36
2018-05-03 13F-HR Trexquant Investment LP 30,725 59,796 94.62 1,231 2,395 94.56
2018-05-15 13F-HR Vivo Capital, LLC 105,000 105,000 0.00 4,205 4,205 0.00
2018-05-14 13F-HR VHCP Management II, LLC 854,057 362,010 -57.61 34,205 14,499 -57.61
2018-05-11 13F-HR KNOTT DAVID M 11,500 20,000 73.91 461 801 73.75
2018-05-09 13F-HR ENVESTNET ASSET MANAGEMENT INC 774 916 18.35 31 37 19.35
2018-05-15 13F-HR Adage Capital Partners GP LLC 275,000 575,000 109.09 11,014 23,029 109.09
2018-05-07 13F-HR BAILARD, INC. 132,100 103,100 -21.95 5,291 4,129 -21.96
2018-05-15 13F-HR AQR CAPITAL MANAGEMENT LLC 69,958 99,747 42.58 2,802 3,995 42.58
2018-05-15 13F-HR HONKAMP KRUEGER FINANCIAL SERVICES INC /ADV 108 4
2018-05-15 13F-HR FARALLON CAPITAL MANAGEMENT LLC 850,000 1,576,000 85.41 34,043 63,119 85.41
2018-04-26 13F-HR SIMPLEX TRADING, LLC 0 17,181 0 688
2018-05-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 3,714 3,714 0.00 148 149 0.68
2018-05-14 13F-HR NOMURA ASSET MANAGEMENT CO LTD 0 0
2018-05-15 13F-HR Atika Capital Management LLC 54,000 50,000 -7.41 2,162 2,002 -7.40
2018-05-04 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 15,120 16,373 8.29 606 656 8.25
2018-04-18 13F-HR/A FNY Managed Accounts LLC Call 15 0 -100.00 0 0
2018-05-14 13F-HR ProShare Advisors LLC 23,535 20,212 -14.12 943 809 -14.21
2018-05-03 13F-HR SG Americas Securities, LLC 0 2,499 0 100
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 152,000 111,900 -26.38 6,088 4,482 -26.38
2018-05-11 13F-HR CITADEL ADVISORS LLC 74,047 2,966
2018-05-15 13F-HR Point72 Asia (Hong Kong) Ltd 36 1
2018-05-15 13F-HR DRIEHAUS CAPITAL MANAGEMENT LLC 137,765 0 -100.00 5,517 0 -100.00
2018-05-14 13F-HR Crawford Lake Capital Management, LLC Call 114,200 0 -100.00 4,574 0 -100.00
2018-05-14 13F-HR Signition Lp 17,137 0 -100.00 686,000 0 -100.00
2018-05-15 13F-HR STATE STREET CORP 905,087 0 -100.00 36,250 0 -100.00
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 213,086 76,613 -64.05 8,534 3,068 -64.05
2018-05-15 13F-HR DAFNA Capital Management LLC 134,147 94,264 -29.73 5,373 3,775 -29.74
2018-05-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 8,154 7,514 -7.85 327 301 -7.95
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 32,764 37,064 13.12 1,312 1,484 13.11
2018-05-14 13F-HR Eversept Partners, Llc 218,378 204,546 -6.33 8,746 8,192 -6.33
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ Put 50,000 0 -100.00 2,003 0 -100.00
2018-05-15 13F-HR Metlife Investment Advisors, Llc 16,721 16,721 0.00 670 670 0.00
2018-05-11 13F-HR HAP Trading, LLC 48,746 1,952
2018-05-14 13F-HR UNITED SERVICES AUTOMOBILE ASSOCIATION 6,019 241
2018-05-04 13F-HR Swiss National Bank 51,000 56,600 10.98 2,043 2,267 10.96
2018-05-10 13F-HR Artal Group S.A. 200,000 8,010
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 2,920 2,920 0.00 117 117 0.00
2018-05-15 13F-HR SECOR Capital Advisors, LP 7,597 304
2018-05-15 13F-HR Shanda Payment Holdings Ltd. 10,000 10,000 0.00 401 401 0.00
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 36,384 35,478 -2.49 1,457 1,421 -2.47
2018-05-11 13F-HR CITIGROUP INC 25,891 6,704 -74.11 1,037 268 -74.16
2018-05-14 13F-HR EAM Investors, LLC 77,937 82,348 5.66 3,121 3,298 5.67
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 37 60 62.16 1 2 100.00
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC Call 0 2,500 0 100
2018-05-11 13F-HR Russell Investments Group, Ltd. 4,291 0 -100.00 181 0 -100.00
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 462 224 -51.52 607 115 -81.05
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 0 1,306 0 53
2018-05-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC Call 0 150 0 601
2018-05-15 13F-HR Voya Investment Management LLC 15,000 15,000 0.00 601 601 0.00
2018-05-07 13F-HR CHICAGO EQUITY PARTNERS LLC 30,975 30,610 -1.18 1,241 1,226 -1.21
2018-05-15 13F-HR CREDIT SUISSE AG/ 168,295 76,579 -54.50 6,740 3,066 -54.51
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 7,080 7,445 5.16 283,554 298,172 5.16
2018-05-14 13F-HR ASCEND CAPITAL, LLC 101,401 104,826 3.38 4,062 4,199 3.37
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 16,600 665
2018-05-15 13F-HR Marshall Wace North America L.P. 13,510 0 -100.00 541 0 -100.00
2018-05-15 13F-HR Squarepoint Ops LLC 11,997 0 -100.00 480 0 -100.00
2018-05-14 13F-HR KENNEDY CAPITAL MANAGEMENT, INC. 187,598 175,923 -6.22 7,513 7,046 -6.22
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 93,855 95,372 1.62 3,759 3,820 1.62
2018-05-14 13F-HR Vident Investment Advisory, LLC 12,377 496
2018-05-14 13F-HR FMR LLC / Fidelity 1,559,290 1,531,140 -1.81 62,449 61,322 -1.80
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 28,500 1,141
2018-05-15 13F-HR DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 15,300 613
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 12,269 74,047 503.53 491 2,966 504.07
2018-05-02 13F-HR Daiwa Securities Group Inc. 189 8
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 5,208 85 -98.37 209 3 -98.56
2018-05-14 13F-HR DLD Asset Management, LP Call 0 51,800 0 2,073
2017-02-10 13F-HR BlackRock Investment Management, LLC 106,418 105,531 -0.83 1,216 1,282 5.43
2018-04-20 13F-HR Seacrest Wealth Management, Llc 100 0 -100.00 4 0 -100.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 545,753 623,898 14.32 21,857 24,987 14.32
2018-05-11 13F-HR Cutler Group LP 6,603 10,703 62.09 264 428 62.12
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 458,404 456,131 -0.50 18,363 18,268 -0.52
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 1,211,793 183,037 -84.90 48,532 7,331 -84.89
2018-05-15 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 30,000 30,000 0.00 1,202 1,202 0.00
2018-05-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 10,861 11,189 3.02 435 448,140 102,920.69
2018-05-09 13F-HR GAGNON SECURITIES LLC 38,460 27,126 -29.47 1,540 1,086 -29.48
2018-05-15 13F-HR PERCEPTIVE ADVISORS LLC 3,970,357 3,970,357 0.00 160,799 159,012 -1.11
2018-05-15 13F-HR SCOPIA CAPITAL MANAGEMENT LP 3,420,599 3,471,638 1.49 136,995 139,039 1.49
2018-05-15 13F-HR Rock Springs Capital Management LP 225,500 225,500 0.00 9,031 9,031 0.00
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 26 34 30.77 2 2 0.00
2018-05-14 13F-HR EMORY UNIVERSITY 48,843 63,499 30.01 1,956 2,543 30.01
2018-05-15 13F-HR PEAK6 Investments, L.P. 0 3,202 0 128
2018-05-10 13F-HR Flinton Capital Management LLC 10,200 409
2018-05-10 13F-HR FRANKLIN RESOURCES INC 846,725 875,425 3.39 33,911 35,061 3.39
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 82 125 52.44 23 22 -4.35
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 11,484 11,522 0.33 460 461 0.22
2018-05-15 13F-HR Wellington Management Group LLP 0 40,717 0 1,631
2018-05-15 13F-HR WOLVERINE TRADING, LLC Call 87,100 3,488
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 35,488 36,003 1.45 1,422 1,442 1.41
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 36,472 0 -100.00 1,461 0 -100.00
2018-05-15 13F-HR RA Capital Management, LLC 1,145,268 1,145,268 0.00 45,868 45,868 0.00
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 71,312 86,312 21.03 2,856 3,457 21.04
2018-05-17 13F-HR Legal & General Group Plc 8,474 6,357 -24.98 344 255 -25.87
2018-05-14 13F-HR Renaissance Technologies LLC 140,441 67,387 -52.02 5,625 2,699 -52.02
2018-05-15 13F-HR ACUTA CAPITAL PARTNERS, LLC 300,000 0 -100.00 12,015 0 -100.00
2018-05-03 13F-HR Zurcher Kantonalbank (Zurich Cantonalbank) 1,005 1,868 85.87 40 75 87.50
2018-05-07 13F-HR STATE OF WISCONSIN INVESTMENT BOARD 31,600 31,600 0.00 1,266 1,266 0.00
2018-05-09 13F-HR Candriam Luxembourg S.C.A. 62,000 86,000 38.71 2,483 3,444 38.70
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 59,150 56,400 -4.65 2,369 2,259 -4.64
2018-06-14 13F-HR/A Dynamic Technology Lab Private Ltd 0 9,179 0 368
2018-05-15 13F-HR Kazazian Asset Management, LLC 16,268 16,268 0.00 652 652 0.00
2018-05-15 13F-HR J. Goldman & Co LP Put 97,500 0 -100.00 3,905 0 -100.00
2018-05-08 13F-HR TEACHER RETIREMENT SYSTEM OF TEXAS 10,215 7,164 -29.87 409 287 -29.83
ZGNX: Zogenix Analysis and Research Report

2018-04-30 - Asif

Company Overview The company currently own and control worldwide development and commercialization rights to ZX008, its lead Phase 3 product candidate. ZX008 is low-dose fenfluramine for the treatment of seizures associated with two rare and catastrophic forms of childhood-onset epilepsy: Dravet syndrome and Lennox-Gastaut syndrome (“LGS”). Dravet syndrome is a rare form of pediatric-onset epilepsy with life threatening consequences for patients and for which current treatment options are very limited. ZX008 has received orphan drug designation in the United States and the European Union (“the EU”) for the treatment of Dravet syndrome. In addition, ZX008 for the treatment of Dravet syndrome received Fast Track designation from the U.S. Food and Drug Administration (the “FDA”) in January 2016 and Breakthrough Therapy designation in February 2018. The company initiated its Phase 3 clinical trials in North America (Study 1501) in January 2016 and in Europe and Australia in J...

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

IOMachine Runthroughs: Buy GW Pharma On Current Approval And Future Catalysts

2018-07-17 seekingalpha
The Input-Output Machine, or IOMachine, is a new analysis tool we developed for our subscribers at the Total Pharma Tracker. This takes a biotech ticker as input and outputs an opinion based on four simple factors - one, presence of upcoming catalyst, mainly in the form of late stage lead candidate trial data or PDUFA; two; previous trial performance analysis of that lead candidate in the specific indication where it has a catalyst; three, cash and burn and general management ability to run the company through the catalyst and after; and four, competition and market potential. (3-0)

Zogenix (ZGNX) in Focus: Stock Moves 9.8% Higher

2018-07-16 zacks
Zogenix, Inc. (ZGNX - Free Report) was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $42.60 to $48.15 in the past one-month time frame. (3-0)

Biotech Analysis Central Pharma News: Zogenix's Late-Stage Win, Zynerba's Bounce Back, Abbvie's Expanded Venetoclax Use

2018-07-16 seekingalpha
Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. (9-1)

Your Daily Pharma Scoop: Zogenix Zooms, Zynerba's Changing Fortunes, AbbVie Proceeds

2018-07-15 seekingalpha
Discussion: Zogenix (ZGNX) announced positive result of a second Phase 3 clinical trial of its ZX008 (low-dose fenfluramine hydrochloride) in Dravet syndrome. The disease is a rare and severe form of epilepsy in children and young adults. Patients in the group under trial experienced a significant betterment, of 54.7% (compared to placebo) decrease in mean monthly convulsive seizures. Both the key secondary endpoints were also met by the trial results. (25-0)

Zogenix's Epilepsy Candidate Successful in Phase III Study

2018-07-13 zacks
Zogenix, Inc. (ZGNX - Free Report) announced successful completion of its second confirmatory phase III study (Study 1504) evaluating its pipeline candidate, ZX008 (low-dose fenfluramine hydrochloride), for treating Dravet syndrome, a type of epilepsy in children and young adults. (5-0)

CUSIP: 98978L105